EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator

Yuki Hamano, Takashi Okude, Osamu Yokosuka, Makoto Ogawa

Nephron Extra · 2011

DOI: 10.1159/000331704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephron Extra, 2011. Verfasst von Yuki Hamano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Chiba University Hospital, Chiba, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Anti-glomerular basement membrane (GBM) nephritis is characterized by activation of the renin-angiotensin system. This study aimed to determine the question of whether a temporary angiotensin II blockade at the initial stage of anti-GBM nephritis is able to attenuate the disease as well as differences in renoprotection among angiotensin II receptor blockers (ARBs) with distinct peroxisome proliferator-activated receptor (PPAR)-γ-modulating activities.

Methods

C57BL/6J mice were immunized with rabbit IgG, followed by intravenous injection of rabbit anti-mouse antibodies. Mice were then treated with telmisartan, losartan, and telmisartan + GW9662 (a PPAR-γ antagonist) for 5 days, or hydralazine for 9 days. On days 8 and 13, mice were sacrificed to obtain tissues for histological analysis.

Results

The temporary administration of telmisartan significantly suppressed glomerular damage compared to hydralazine. Losartan showed a similar effect but was less effective. Co-administration of GW9662 attenuated the renoprotective effect of telmisartan, almost to levels observed with losartan. In particular, it limited the decreased infiltration of inflammatory cells and preservation of capillaries in the glomeruli induced by telmisartan.

Conclusion

Temporary angiotensin II blockade at the initial stage of anti-GBM disease dramatically inhibited its progression. In addition to a class effect of ARBs, telmisartan modified inflammation and endothelial damage in the kidney through its PPAR-γ-agonistic action.

Schlagwörter

Stichwörter der Autor:innen

Angiotensin II receptor blockerGlomerular basement membraneNephritisPeroxisome proliferator-activated receptor-γ

Autor:innen und Institutionen

  • Department of Nephrology, Chiba University Hospital, Chiba, Japan.

Zitieren

APA

Hamano, Y., Okude, T., Yokosuka, O., & Ogawa, M. (2011). Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator. Nephron Extra. https://doi.org/10.1159/000331704

Vancouver

Hamano Y, Okude T, Yokosuka O, Ogawa M. Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator. Nephron Extra. 2011. doi:10.1159/000331704

BibTeX
@article{Hamano2011,
  author = {Hamano, Yuki and Okude, Takashi and Yokosuka, Osamu and Ogawa, Makoto},
  title = {Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator},
  journal = {Nephron Extra},
  year = {2011},
  doi = {10.1159/000331704}
}
Kostenlos starten →